MTX101 2mg

· Manistee Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MTX101 2mg, covering 2025-10-07 to 2025-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults [Phase 2]